DekaBank Deutsche Girozentrale’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $225M | Hold |
506,457
| – | – | 0.38% | 62 |
|
|
2026
Q1 | $230M | Hold |
506,457
| – | – | 0.38% | 62 |
|
|
2025
Q4 | $220M | Hold |
506,457
| – | – | 0.38% | 54 |
|
|
2025
Q3 | $200M | Hold |
506,457
| – | – | 0.34% | 66 |
|
|
2025
Q2 | $223M | Buy |
506,457
+15,328
| +3% | +$7.06M | 0.4% | 60 |
|
|
2025
Q1 | $239M | Sell |
491,129
-15,328
| -3% | -$7.14M | 0.47% | 46 |
|
|
2024
Q4 | $205M | Hold |
506,457
| – | – | 0.38% | 59 |
|
|
2024
Q3 | $233M | Buy |
506,457
+4,948
| +1% | +$2.38M | 0.43% | 52 |
|
|
2024
Q2 | $237M | Buy |
501,509
+10,380
| +2% | +$4.51M | 0.43% | 51 |
|
|
2024
Q1 | $204M | Sell |
491,129
-12,849
| -3% | -$5.43M | 0.38% | 61 |
|
|
2023
Q4 | $206M | Buy |
503,978
+33,920
| +7% | +$12.5M | 0.42% | 50 |
|
|
2023
Q3 | $166M | Buy |
470,058
+4,020
| +0.9% | +$1.41M | 0.38% | 55 |
|
|
2023
Q2 | $163M | Buy |
466,038
+13,635
| +3% | +$4.59M | 0.37% | 60 |
|
|
2023
Q1 | $141M | Buy |
452,403
+18,758
| +4% | +$5.63M | 0.35% | 64 |
|
|
2022
Q4 | $125M | Buy |
433,645
+10,927
| +3% | +$3.33M | 0.33% | 76 |
|
|
2022
Q3 | $123M | Sell |
422,718
-49,786
| -11% | -$14.3M | 0.36% | 62 |
|
|
2022
Q2 | $131M | Sell |
472,504
-7,636
| -2% | -$2.04M | 0.38% | 57 |
|
|
2022
Q1 | $124M | Buy |
480,140
+141,885
| +42% | +$33.7M | 0.3% | 79 |
|
|
2021
Q4 | $76M | Sell |
338,255
-6,454
| -2% | -$1.26M | 0.18% | 126 |
|
|
2021
Q3 | $63M | Buy |
344,709
+8,784
| +3% | +$1.72M | 0.18% | 139 |
|
|
2021
Q2 | $66.1M | Buy |
335,925
+38,249
| +13% | +$8M | 0.19% | 135 |
|
|
2021
Q1 | $63.6M | Buy |
297,676
+63,181
| +27% | +$13.9M | 0.21% | 123 |
|
|
2020
Q4 | $54.7M | Sell |
234,495
-20,913
| -8% | -$4.8M | 0.21% | 119 |
|
|
2020
Q3 | $68.3M | Buy |
255,408
+193,226
| +311% | +$53.3M | 0.3% | 81 |
|
|
2020
Q2 | $17.7M | Buy |
62,182
+3,733
| +6% | +$1.01M | 0.11% | 141 |
|
|
2020
Q1 | $13.7M | Sell |
58,449
-2,895
| -5% | -$664K | 0.1% | 144 |
|
|
2019
Q4 | $13.5M | Sell |
61,344
-171,690
| -74% | -$34.7M | 0.08% | 184 |
|
|
2019
Q3 | $39M | Sell |
233,034
-141,130
| -38% | -$25M | 0.24% | 95 |
|
|
2019
Q2 | $67M | Buy |
374,164
+267,507
| +251% | +$46.8M | 0.34% | 76 |
|
|
2019
Q1 | $20M | Buy |
106,657
+3,474
| +3% | +$642K | 0.12% | 192 |
|
|
2018
Q4 | $16.9M | Sell |
103,183
-3,474
| -3% | -$602K | 0.11% | 191 |
|
|
2018
Q3 | $20M | Sell |
106,657
-30,777
| -22% | -$5.48M | 0.12% | 193 |
|
|
2018
Q2 | $20.7M | Sell |
137,434
-39,965
| -23% | -$6.2M | 0.13% | 183 |
|
|
2018
Q1 | $28.5M | Buy |
177,399
+24,037
| +16% | +$3.93M | 0.2% | 134 |
|
|
2017
Q4 | $23.3M | Hold |
153,362
| – | – | 0.18% | 137 |
|
|
2017
Q3 | $23.3M | Sell |
153,362
-23,072
| -13% | -$3.47M | 0.18% | 137 |
|
|
2017
Q2 | $22.6M | Buy |
176,434
+5,253
| +3% | +$632K | 0.18% | 136 |
|
|
2017
Q1 | $18.5M | Buy |
171,181
+1,006
| +0.6% | +$88.6K | 0.17% | 129 |
|
|
2016
Q4 | $12.7M | Sell |
170,175
-13,396
| -7% | -$1.09M | 0.14% | 164 |
|
|
2016
Q3 | $15.6M | Sell |
183,571
-67,830
| -27% | -$6.41M | 0.17% | 138 |
|
|
2016
Q2 | $21.4M | Buy |
251,401
+15,692
| +7% | +$1.36M | 0.24% | 98 |
|
|
2016
Q1 | $18.5M | Buy |
235,709
+43,292
| +22% | +$3.92M | 0.22% | 105 |
|
|
2015
Q4 | $24.6M | Sell |
192,417
-39,960
| -17% | -$4.82M | 0.28% | 80 |
|
|
2015
Q3 | $23.7M | Buy |
232,377
+51,146
| +28% | +$6.57M | 0.29% | 73 |
|
|
2015
Q2 | $22.5M | Buy |
181,231
+7,542
| +4% | +$950K | 0.27% | 72 |
|
|
2015
Q1 | $20.8M | Buy |
173,689
+7,000
| +4% | +$839K | 0.26% | 83 |
|
|
2014
Q4 | $19.9M | Sell |
166,689
-7,046
| -4% | -$794K | 0.25% | 91 |
|
|
2014
Q3 | $19.7M | Sell |
173,735
-45,355
| -21% | -$4.32M | 0.27% | 84 |
|
|
2014
Q2 | $20.5M | Buy |
219,090
+4,650
| +2% | +$326K | 0.31% | 75 |
|
|
2014
Q1 | $14.6M | Buy |
214,440
+34,230
| +19% | +$2.71M | 0.23% | 96 |
|
|
2013
Q4 | $13.3M | Buy |
180,210
+24,266
| +16% | +$1.69M | 0.22% | 93 |
|
|
2013
Q3 | $11.7M | Buy |
155,944
+4,297
| +3% | +$342K | 0.21% | 96 |
|
|
2013
Q2 | $12.2M | Buy |
+151,647
| New | +$11.2M | 0.24% | 87 |
|
Other funds holding VRTX
DekaBank Deutsche Girozentrale's VRTX Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 506,457 shares worth $225M. The position accounts for 0.38% of the portfolio, ranked #62.
DekaBank Deutsche Girozentrale first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $239M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- DekaBank Deutsche Girozentrale held 506,457 shares of Vertex Pharmaceuticals worth $225M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up 0.38% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #62 holding.
- DekaBank Deutsche Girozentrale first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- DekaBank Deutsche Girozentrale's Vertex Pharmaceuticals position peaked at $239M in Q1 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.